Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

20n

20n
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
$120K LATEST DEAL AMOUNT
8 INVESTORS
Description

Operator of a computational synthetic biology company. The company uses algorithms to engineer microbes to produce chemicals with therapeutic health and industrial biotech applications. It provides the computational systems that predict DNA design for novel industrial biotech and health applications.

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Application Software
Primary Office
  • San Francisco, CA
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore 20n’s full profile, request a free trial.

20n Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 24-Mar-2015 $120K 00000 00.000 Completed Startup
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

20n Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Y Combinator Accelerator/Incubator Minority 000 0000 000000 0
Blumberg Capital Venture Capital Minority 000 0000 000000 0
Eric Kwan Angel (individual) Minority 000 0000 000000 0
Great Oaks Venture Capital Venture Capital Minority 000 0000 000000 0
Khosla Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

20n Executive Team (2)

Name Title Board
Seat
Contact
Info
Saurabh Srivastava Ph.D Co-Founder & Chief Executive Officer

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »